Rchr
J-GLOBAL ID：200901022712878748   Update date: Jun. 29, 2023

Morikawa Norifumi

モリカワ ノリフミ | Morikawa Norifumi
Affiliation and department：
Hiroshima University

About Hiroshima University


Papers (189)：
  • Kaiki, Yuki, Ohge, Hiroki, Ikawa, Kazuro, Uegami, Shinnosuke, Watadani, Yusuke, Shigemoto, Norifumi, Hirano, Toshinori, Yoshimura, Kosuke, Kitagawa, Hiroki, Morikawa, Norifumi, et al. Pharmacokinetics of cefmetazole in plasma, peritoneal fluid, peritoneum, and subcutaneous adipose tissue of patients scheduled for lower gastrointestinal surgery: Dosing considerations based on site-specific pharmacodynamic target attainment. JOURNAL OF INFECTION AND CHEMOTHERAPY. 2023. 29. 3. 309-315
  • Onita, Tetsushu, Ikawa, Kazuro, Ishihara, Noriyuki, Tamaki, Hiroki, Yano, Takahisa, Naora, Kohji, Morikawa, Norifumi. Pulmonary Pharmacokinetic and Pharmacodynamic Evaluation of Ampicillin/Sulbactam Regimens for Pneumonia Caused by Various Bacteria, including Acinetobacter baumannii. ANTIBIOTICS-BASEL. 2023. 12. 2. 303-303
  • Hirano, Toshinori, Ohge, Hiroki, Ikawa, Kazuro, Uegami, Shinnosuke, Watadani, Yusuke, Shigemoto, Norifumi, Yoshimura, Kosuke, Kitagawa, Hiroki, Kaiki, Yuki, Morikawa, Norifumi, et al. Pharmacokinetics of flomoxef in plasma, peritoneal fluid, peritoneum, and subcutaneous adipose tissue of patients undergoing lower gastrointestinal surgery: Dosing considerations based on site-specific pharmacodynamic target attainment. JOURNAL OF INFECTION AND CHEMOTHERAPY. 2023. 29. 2. 186-192
  • Onita, Tetsushu, Ishihara, Noriyuki, Ikebuchi, Amika, Yano, Takahisa, Nishimura, Nobuhiro, Tamaki, Hiroki, Ikawa, Kazuro, Morikawa, Norifumi, Naora, Kohji. Pharmacokinetic and pharmacodynamic simulation for the quantitative risk assessment of linezolid-associated thrombocytopenia. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2022. 47. 12. 2041-2048
  • Umezaki, Yasuhiro, Matsumoto, Kazuaki, Ikawa, Kazuro, Yokoyama, Yuta, Enoki, Yuki, Shigemi, Akari, Watanabe, Erika, Nakamura, Koyo, Ueno, Keiichiro, Terazono, Hideyuki, et al. Concentration-Dependent Activity of Pazufloxacin against Pseudomonas aeruginosa: An In Vivo Pharmacokinetic/Pharmacodynamic Study. ANTIBIOTICS-BASEL. 2022. 11. 7
ｍore...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM